Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:Q8WXG1 RSAD2

Class:IdReferenceGeneProduct:246567
_chainChangeLogchain:1-361 added on Fri February 6 2015
_displayNameUniProt:Q8WXG1 RSAD2
_timestamp2025-05-21 21:08:23
chainchain:1-361
checksumED014743CE1568DF
commentFUNCTION Interferon-inducible antiviral protein which plays a major role in the cell antiviral state induced by type I and type II interferon (PubMed:31812350). Catalyzes the conversion of cytidine triphosphate (CTP) to 3'-deoxy-3',4'-didehydro-CTP (ddhCTP) via a SAM-dependent radical mechanism (PubMed:29925952, PubMed:30872404). In turn, ddhCTP acts as a chain terminator for the RNA-dependent RNA polymerases from multiple viruses and directly inhibits viral replication (PubMed:29925952). Therefore, inhibits a wide range of DNA and RNA viruses, including human cytomegalovirus (HCMV), hepatitis C virus (HCV), west Nile virus (WNV), dengue virus, sindbis virus, influenza A virus, sendai virus, vesicular stomatitis virus (VSV), zika virus, and human immunodeficiency virus (HIV-1) (PubMed:29925952, PubMed:30587778, PubMed:30934824, PubMed:31921110). Also promotes TLR7 and TLR9-dependent production of IFN-beta production in plasmacytoid dendritic cells (pDCs) by facilitating 'Lys-63'-linked ubiquitination of IRAK1 by TRAF6 (PubMed:30872404). Plays a role in CD4+ T-cells activation and differentiation. Facilitates T-cell receptor (TCR)-mediated GATA3 activation and optimal T-helper 2 (Th2) cytokine production by modulating NFKB1 and JUNB activities. Can inhibit secretion of soluble proteins.CATALYTIC ACTIVITY CTP + AH2 + S-adenosyl-L-methionine = 3'-deoxy-3',4'-didehydro-CTP + 5'-deoxyadenosine + L-methionine + A + H2O + H(+)COFACTOR Binds 1 [4Fe-4S] cluster. The cluster is coordinated with 3 cysteines and an exchangeable S-adenosyl-L-methionine.ACTIVITY REGULATION IRAK1 and TRAF6 synergistically activate RSAD2 increasing its activity with CTP as substrate about 10-fold.SUBUNIT Homodimer. Interacts with IRAK1 and TRAF6 (PubMed:30872404, PubMed:31921110). Interacts with FPPS (PubMed:18005724). Interacts with HADHB (PubMed:21527675). Interacts (via C-terminus) with VAPA/VAP33 (via C-terminus) (PubMed:21957124).SUBUNIT (Microbial infection) Interacts with human cytomegalovirus/HHV-5 protein vMIA/UL37; this interaction results in RSAD2/viperin relocalization from the endoplasmic reticulum to the mitochondria.SUBUNIT (Microbial infection) Interacts (via N-terminus) with enterovirus A71 protein 2C; this interaction inhibits viral replication.SUBUNIT (Microbial infection) Interacts with herpes simplex virus 1/HHV-1 glycoprotein D; this interaction inhibits HHV-1 replication by facilitating IRF7-mediated IFN-beta production.INTERACTION Infection with human cytomegalovirus (HCMV) causes relocation to the Golgi apparatus and to cytoplasmic vacuoles which also contain HCMV proteins glycoprotein B and pp28. Interaction with human cytomegalovirus/HHV-5 protein vMIA/UL37 results in its relocalization from the endoplasmic reticulum to the mitochondria.INDUCTION By interferon type I, type II and bacterial lipopolysaccharides (LPS). Little or no induction by IFNG/IFN-gamma is observed in monocytic cell lines. Induced by infection with hepatitis C virus, yellow fever virus and Sendai virus, presumably through type I interferon pathway. Induction by infection with human cytomegalovirus (HCMV), stomatitis virus (VSV), chikungunya virus (CHIKV), Japanese encephalitis virus (JEV) occurs independent of the IFN pathway.DOMAIN The N-terminal region (1-42) is necessary for its localization to the endoplasmic reticulum membrane and lipid droplet.PTM Acetylated by HAT1. HAT1-mediated acetylation of Lys-197 in turn recruits UBE4A that stimulates RSAD2 polyubiquitination leading to proteasomal degradation.PTM 'Lys-6'-linked polyubiquitination at Lys-206 leads to RSAD2 protein degradation.MISCELLANEOUS Up-regulated in atherosclerosis. Latent viruses like HCMV may be involved in atherogenesis by initiating local inflammation. This may induce up-regulation of antiviral gene RSAD2, which modulates lipids synthesis, and thus could play a role in abnormal lipid accumulation leading to atherosclerosis.SIMILARITY Belongs to the radical SAM superfamily. RSAD2 family.
created[InstanceEdit:217385] Schmidt, EE, 2008-03-27 06:23:53
descriptionrecommendedName: fullName evidence="27"S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 shortName evidence="27"SAND ecNumber evidence="17 19"4.2.-.- alternativeName: fullName evidence="28"Cytomegalovirus-induced gene 5 protein alternativeName: fullName evidence="35"Radical S-adenosyl methionine domain-containing protein 2 alternativeName: fullName evidence="24"Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible shortName evidence="24 25 26"Viperin
geneNameRSAD2
CIG5
identifierQ8WXG1
isSequenceChangedFALSE
keyword4Fe-4S
Acetylation
Antiviral defense
Atherosclerosis
Endoplasmic reticulum
Golgi apparatus
Host-virus interaction
Immunity
Innate immunity
Iron
Iron-sulfur
Isopeptide bond
Lipid droplet
Lyase
Membrane
Metal-binding
Mitochondrion
Mitochondrion inner membrane
Mitochondrion outer membrane
Proteomics identification
Reference proteome
S-adenosyl-L-methionine
Ubl conjugation
modified[InstanceEdit:9836292] Weiser, Joel, 2023-05-25
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9917590] Weiser, Joel, 2024-08-09
[InstanceEdit:9926675] Weiser, Joel, 2024-11-03
[InstanceEdit:9939033] Weiser, Joel, 2025-02-21
[InstanceEdit:9948485] Weiser, Joel, 2025-05-21
nameRSAD2
referenceDatabase[ReferenceDatabase:2] UniProt
referenceGene[ReferenceDNASequence:8992709] ENSEMBL:ENSG00000134321 RSAD2 [Homo sapiens]
secondaryIdentifierRSAD2_HUMAN
Q8WVI4
sequenceLength361
species[Species:48887] Homo sapiens
(referenceEntity)[EntityWithAccessionedSequence:5624199] RSAD2 [endoplasmic reticulum membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9981423] RSAD2 [lipid droplet] [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:Q8WXG1 RSAD2 (246567)